Individualized atomoxetine response and tolerability in children with ADHD receiving different dosag...
Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance together
About this item
Full title
Author / Creator
Guo, Hong-Li , Wu, Dan-Dan , Fu, Di , Li, Yue , Wang, Jie , Zhang, Yuan-Yuan , Wang, Wei-Jun , Huang, Jian , Fang, Wei-Rong , Xu, Jing , Hu, Ya-Hui , Liu, Qian-Qi and Chen, Feng
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Integrating
CYP2D6
genotyping and therapeutic drug monitoring (TDM) is crucial for guiding individualized atomoxetine therapy in children with attention-deficit/hyperactivity disorder (ADHD). The aim of this retrospective study was (1) to investigate the link between the efficacy and tolerability of atomoxetine in children with ADHD and plasm...
Alternative Titles
Full title
Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance together
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6b1769d95e25434d89723d5330a28112
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6b1769d95e25434d89723d5330a28112
Other Identifiers
ISSN
2158-3188
E-ISSN
2158-3188
DOI
10.1038/s41398-024-02859-2
